Furthermore, RT-qPCR showed no significant increase in BCL9L expression in DCIS MIND xenografts during invasive transition from 2 to 10 weeks (Additional file 5: Figure S2B-C). This evidence concerns the gene BCL9L and ductal breast carcinoma in situ.